Case Application: Patients With EGFRm Resistance Post TKI and Platinum Chemotherapy
Pasi Antero Jänne, MD, PhD
Helena Yu, MD
Biologic Rationale for Targeting HER3 and Role in EGFR Resistance
Case Application: Adverse Event Management of Patients With EGFRm Resistance Treated With Novel HER3-Directed ADCs
The Weight of Recurrence: Navigating Multidisciplinary Care Planning in Recurring/Metastatic Cervical Cancer
Brian Slomovitz, MD
Robert L. Coleman, MD, FACOG, FACS
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
Nataliya Uboha, MD, PhD
Bringing Treatment Into Focus: Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Cancers
David H. Ilson, MD, PhD
Sunnie Kim, MD
Loading...
We're glad to see you're enjoying MedEd On The Go… but how about a more personalized experience?
Press cancel to remain on MedEd On The Go. Press the link below or the continue button to keep going.